These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 22952422)

  • 1. Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer.
    Weekes CD; Song D; Arcaroli J; Wilson LA; Rubio-Viqueira B; Cusatis G; Garrett-Mayer E; Messersmith WA; Winn RA; Hidalgo M
    Neoplasia; 2012 Aug; 14(8):690-701. PubMed ID: 22952422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
    Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.
    Javle MM; Shroff RT; Xiong H; Varadhachary GA; Fogelman D; Reddy SA; Davis D; Zhang Y; Wolff RA; Abbruzzese JL
    BMC Cancer; 2010 Jul; 10():368. PubMed ID: 20630061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF.
    Ishikawa D; Takeuchi S; Nakagawa T; Sano T; Nakade J; Nanjo S; Yamada T; Ebi H; Zhao L; Yasumoto K; Nakamura T; Matsumoto K; Kagamu H; Yoshizawa H; Yano S
    PLoS One; 2013; 8(5):e62104. PubMed ID: 23690929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.
    Zeng Z; Shi YX; Samudio IJ; Wang RY; Ling X; Frolova O; Levis M; Rubin JB; Negrin RR; Estey EH; Konoplev S; Andreeff M; Konopleva M
    Blood; 2009 Jun; 113(24):6215-24. PubMed ID: 18955566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SDF-1α/CXCR4 axis is required for proliferation and maturation of human fetal pancreatic endocrine progenitor cells.
    Kayali AG; Lopez AD; Hao E; Hinton A; Hayek A; King CC
    PLoS One; 2012; 7(6):e38721. PubMed ID: 22761699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.
    Kobayashi K; Sato K; Kida T; Omori K; Hori M; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1716-22. PubMed ID: 24925969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs).
    Sameermahmood Z; Balasubramanyam M; Saravanan T; Rema M
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3305-11. PubMed ID: 18660423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
    Lee BC; Lee TH; Avraham S; Avraham HK
    Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines.
    Pan F; Ma S; Cao W; Liu H; Chen F; Chen X; Shi R
    Mol Biol Rep; 2013 Jul; 40(7):4139-46. PubMed ID: 23712777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inhibition induces EGFR feedback activation in association with its resistance to human pancreatic cancer.
    Wei F; Zhang Y; Geng L; Zhang P; Wang G; Liu Y
    Int J Mol Sci; 2015 Feb; 16(2):3267-82. PubMed ID: 25654224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts.
    Chen HT; Tsou HK; Hsu CJ; Tsai CH; Kao CH; Fong YC; Tang CH
    J Cell Biochem; 2011 Apr; 112(4):1219-27. PubMed ID: 21312239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
    Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
    Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells.
    Zhang H; Wu H; Guan J; Wang L; Ren X; Shi X; Liang Z; Liu T
    Oncotarget; 2015 Feb; 6(5):3085-97. PubMed ID: 25609203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha.
    Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC
    Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
    Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
    Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.